This observation supports the essential idea that live attenuated Listeria immunotherapies can result in long lived responses, by stimulating persistent immune memory possibly.. Advaxis provides upgrade on survival info from ADXS11-001 phase 1 trial in cervix cancer Advaxis, Inc., , the live, attenuated Listeria monocytogenes immunotherapy company, has up to date the survival info from its phase 1 trial of ADXS11-001 which assessed the safety of this agent in advanced, metastatic, progressive cervix malignancy in females whose disease progressed subsequent to treatment with cytotoxic therapy.The study revealed that many at-risk HIV-infected individuals have no idea they are at risk for HCV. More than half of the male individuals who have sex with males reported that they don’t think that risk behaviors such as for example unprotected anal sex or certain drug practices put them at risk for HCV infection. However, Taylor says that self-reported HCV risk and participation in several risk behaviors declined through the scholarly study. This could be described by risk decrease counseling, which was offered at each clinic check out underreporting because of the stigma of a few of these behaviors, or diminished storage of behaviors during chemical use.